Dan Leonard News
-
A takeover of Life Technologies Corp. at one of the lowest multiples on record would still be better for shareholders than no deal at all.
-
Illumina Inc., maker of tools for genetic analysis, fell the most ever after dropping its profit forecast because of concerns that research funding will be reduced, sending shares of rival equipment makers down.
-
Natural gas futures advanced to a five-day high in New York before a government report that may show a below-average inventory increase for last week.
-
Cepheid Inc., the maker of a rapid test for a drug-resistant staph infection known as MRSA, declined after saying research costs will rise in 2012.
-
Immucor Inc., the leading maker of tests to screen blood before transfusions, agreed to sell itself to private-equity firm TPG Capital for $1.97 billion.
-
Roche Holding AG offered about $5.7 billion in cash for Illumina Inc. to bolster cancer-drug sales, the third time since 2007 the Swiss drugmaker has made a hostile bid for a U.S. company.
-
Beckman Coulter Inc. , a maker of laboratory equipment, is exploring a sale after it was approached by buyout firms interested in taking the company private, said people with direct knowledge of the matter.
-
Illumina Inc., the U.S. maker of gene-mapping tools, rose above Roche Holding AG’s increased hostile takeover bid, indicating investors are betting that an even higher offer will come.
-
Cepheid Inc., maker of a rapid test for the drug-resistant staph infection known as MRSA, surged 22 percent in early trading after the company yesterday reported fourth-quarter earnings that beat analysts’ estimates.
-
Danaher Corp., Thermo Fisher Scientific Inc. and several private-equity firms are among those considering offers for laboratory-equipment maker Beckman Coulter Inc. , three people with direct knowledge of the matter said.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page